1. Home
  2. CDNA vs USAS Comparison

CDNA vs USAS Comparison

Compare CDNA & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • USAS
  • Stock Information
  • Founded
  • CDNA 1998
  • USAS 1998
  • Country
  • CDNA United States
  • USAS Canada
  • Employees
  • CDNA N/A
  • USAS N/A
  • Industry
  • CDNA Medical Specialities
  • USAS Metal Mining
  • Sector
  • CDNA Health Care
  • USAS Basic Materials
  • Exchange
  • CDNA Nasdaq
  • USAS Nasdaq
  • Market Cap
  • CDNA 712.2M
  • USAS 815.2M
  • IPO Year
  • CDNA 2014
  • USAS N/A
  • Fundamental
  • Price
  • CDNA $15.19
  • USAS $3.97
  • Analyst Decision
  • CDNA Buy
  • USAS Strong Buy
  • Analyst Count
  • CDNA 8
  • USAS 2
  • Target Price
  • CDNA $26.86
  • USAS $3.33
  • AVG Volume (30 Days)
  • CDNA 1.3M
  • USAS 2.5M
  • Earning Date
  • CDNA 11-03-2025
  • USAS 11-06-2025
  • Dividend Yield
  • CDNA N/A
  • USAS N/A
  • EPS Growth
  • CDNA N/A
  • USAS N/A
  • EPS
  • CDNA 1.00
  • USAS N/A
  • Revenue
  • CDNA $340,826,000.00
  • USAS $96,597,000.00
  • Revenue This Year
  • CDNA $12.73
  • USAS $25.51
  • Revenue Next Year
  • CDNA $11.90
  • USAS $92.20
  • P/E Ratio
  • CDNA $15.23
  • USAS N/A
  • Revenue Growth
  • CDNA 14.72
  • USAS N/A
  • 52 Week Low
  • CDNA $10.96
  • USAS $0.74
  • 52 Week High
  • CDNA $32.76
  • USAS $4.06
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 60.38
  • USAS 80.61
  • Support Level
  • CDNA $14.28
  • USAS $3.70
  • Resistance Level
  • CDNA $15.21
  • USAS $4.06
  • Average True Range (ATR)
  • CDNA 0.60
  • USAS 0.19
  • MACD
  • CDNA 0.02
  • USAS 0.08
  • Stochastic Oscillator
  • CDNA 72.48
  • USAS 93.58

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

Share on Social Networks: